Getting funding for this sort of research is a challenge—the stigmatization of psilocybin has prompted governmental funding bodies to stop projects involving the compound. Nonetheless, Nichols thinks that, as trials demonstrating the likely benefits of psilocybin keep popping out, there may be a larger force and incentive for financial investment. https://edgarwirzi.thenerdsblog.com/36378270/rumored-buzz-on-copyright-mushrooms-california